Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Ibexx who wrote (3437)	6/10/1998 4:02:00 PM
From: Jim Lamb	Read Replies (1) \| Respond to of 9523

All,FYI. Yahoo has something new on stock site = click INSIDER and you get this biz.yahoo.com.

To: Ibexx who wrote (3437)	6/10/1998 4:36:00 PM
From: zonkie	Respond to of 9523

a page about viagra: (jokes) geocities.com

To: Ibexx who wrote (3437)	6/11/1998 10:03:00 PM
From: Ibexx	Respond to of 9523

Thread, The following is from the famed technical analyst Ralph Acampora of Prudential Securities on PFE (although a few days old): brought to you by Ralph Acampora. Chief Technical Analyst. June 11, 1998, 10:20 a.m. EST Prices as of close on 6/10/98 International Perspective Technical Highlights Pfizer (PFE $112 7/16), rated a fundamental hold by the Prudential Securities Research Department, appears to be terminating its two-month corrective phase, suggesting a challenge of its mid-April peaks near $121. Near-term support is anticipated initially from $107, while the major trend exhibits support at the $100 level. Ibexx